Leadership Dec 5, 2022
A 36-year-old CEO saw how psychedelics treated his best friend’s mental illness. Now his Peter Thiel-funded firm wants to bring the drugs to the masses
External link
Leadership Nov 17, 2022
40 Under 40
External link
EmpathBio Nov 10, 2022
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update
External link
Mental Health Oct 5, 2022
How psychedelics and tranquilisers could be the new therapy
External link
Mental Health Sep 28, 2022
Navigating the highs and lows of psychedelic therapies
External link
Mental Health Sep 28, 2022
Taking the tripping out of psychedelic medicine
External link
Mental Health Sep 28, 2022
Psychedelic medicine faces the acid test
External link
atai Sep 28, 2022
Why federal agencies say now is the time to explore psychedelics
External link
atai Sep 27, 2022
Atai Life Sciences launches Phase 1 clinical trial of MDMA derivative
External link